One study showed that diosgenin suppressed the phosphorylation of Vav2 and activation of Cdc42, leading to attenuation of cell migration of breast cancer cells, indicating that diosgenin has a therapeutic potential for metastasis therapy [15]. The gene discussed is CDC42; the disease is breast cancer.